ClinicalTrials.govpublic full text
Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo
moderate to severe ulcerative colitis, ulcerative colitis, inflammatory bowel syndrome, adalimumab, tumor necrosis factor (tnf) alpha antibody, calprotectin, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888145
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.